http://bmctoday.net/evtoday/ The latest news stories from Endovascular Today. en-us Mon, 15 Mar 2010 18:47:13 GMT Mon, 15 Mar 2010 18:47:13 GMT BMCToday http://bmctoday.net/evtoday/2010/02/article.asp?f=fda-approves-boston-scientifics-express-ld-iliac-stent-system March 11, 2010—Boston Scientific Corporation (Natick, MA) announced that the US Food and Drug Administration has approved its Express LD iliac premounted stent system for use in iliac arteries. According to the company, the Express LD iliac stent is designed to be highly deliverable, and its Tandem Architecture stent design is engineered to bala... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/evtoday/2010/02/article.asp?f=fda-approves-boston-scientifics-express-ld-iliac-stent-system http://bmctoday.net/evtoday/2010/02/article.asp?f=rex-medical-cleaner-rotational-thrombectomy-system-receives-510k-clearance March 11, 2010—Rex Medical (Conshohocken, PA) and Argon Medical Devices, Inc. (Athens, TX) announced that Rex’s Cleaner rotational thrombectomy system has received 510(k) clearance from the US Food and Drug Administration. Argon will lead all marketing and distribution efforts for Cleaner in the United States, European Union, and Canada, the co... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/evtoday/2010/02/article.asp?f=rex-medical-cleaner-rotational-thrombectomy-system-receives-510k-clearance http://bmctoday.net/evtoday/2010/02/article.asp?f=st-jude-medicals-engage-introducer-devices-approved-in-united-states-and-europe March 11, 2010—St. Jude Medical, Inc. (St. Paul, MN) announced US Food and Drug Administration clearance and European CE Mark approval for the Engage and Engage TR introducers for use in diagnostic and interventional cardiac catheterization procedures. The Engage family of introducers incorporates features that offer more control and minimize ris... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/evtoday/2010/02/article.asp?f=st-jude-medicals-engage-introducer-devices-approved-in-united-states-and-europe http://bmctoday.net/evtoday/2010/02/article.asp?f=novostentrsquos-samba-receives-ce-mark-to-treat-sfa-and-popliteal-disease March 1, 2010—NovoStent Corporation (Mountain View, CA) announced that it has received CE Mark approval for its Samba stent and delivery system for treating peripheral arterial disease. The Samba stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral and popliteal arteries. According t... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/evtoday/2010/02/article.asp?f=novostentrsquos-samba-receives-ce-mark-to-treat-sfa-and-popliteal-disease http://bmctoday.net/evtoday/2010/02/article.asp?f=lumenrsquos-fibernet-eps-shows-success-in-high-risk-cas-patients-in-epic-study March 1, 2010—The Society for Cardiovascular Angiography and Interventions announced that the multicenter EPIC (FiberNet Embolic Protection System [EPS] in Carotid Artery Stenting [CAS] Trial) study found that the FiberNet EPS (Lumen Biomedical, Inc., Maple Grove, MN) had a 97.5% success rate when used in patients undergoing CAS. Subbarao Myl... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/evtoday/2010/02/article.asp?f=lumenrsquos-fibernet-eps-shows-success-in-high-risk-cas-patients-in-epic-study http://bmctoday.net/evtoday/2010/02/article.asp?f=meta-analysis-reviews-comparative-studies-of-tevar-and-open-surgery March 1, 2010—Findings from a study that sought to determine whether thoracic endovascular aortic repair (TEVAR) reduces death and morbidity compared with open surgical repair for descending thoracic aortic disease were published by Davy Cheng, MD, et al in the Journal of the American College of Cardiology (2010;55:986–1001). The investigat... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/evtoday/2010/02/article.asp?f=meta-analysis-reviews-comparative-studies-of-tevar-and-open-surgery http://bmctoday.net/evtoday/2010/02/article.asp?f=crest-data-show-equivalence-between-cas-and-cea February 26, 2010—Long-awaited results from the CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial) study were presented today for the first time at the American Stroke Association’s Annual International Stroke Conference 2010, which convened on February 24–26 in San Antonio, Texas. The CREST Executive Committee met re... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/evtoday/2010/02/article.asp?f=crest-data-show-equivalence-between-cas-and-cea http://bmctoday.net/evtoday/2010/02/article.asp?f=1.-crest-investigators-present-data-on-credentialing-and-training-for-the-trials-stent-operators February 26, 2010—At the International Stroke Conference 2010, the CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial) investigators presented data on the rigorous two-step credentialing and training for the trial’s stent operators, which aimed to minimize learning-curve effects upon outcomes. They stated that previous random... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/evtoday/2010/02/article.asp?f=1.-crest-investigators-present-data-on-credentialing-and-training-for-the-trials-stent-operators http://bmctoday.net/evtoday/2010/02/article.asp?f=2.-investigators-present-findings-from-the-lead-in,-credentialing-phase-of-crest February 26, 2010—At the International Stroke Conference 2010, the CREST ( Carotid Revascularization Endarterectomy Versus Stent Trial) investigators also presented findings from the lead-in, credentialing phase of CREST regarding changes in carotid luminal diameter at 1 year after stenting. The investigators noted that the incidence of loss of l... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/evtoday/2010/02/article.asp?f=2.-investigators-present-findings-from-the-lead-in,-credentialing-phase-of-crest http://bmctoday.net/evtoday/2010/02/article.asp?f=european-icss-study-concludes-cas-not-as-effective-as-cea-in-the-short-term February 25, 2010—Findings from the International Carotid Stenting Study (ICSS) suggest that in the short-term, carotid artery stenting (CAS) was neither as safe nor as effective at preventing stroke as carotid endarterectomy (CEA). The Lancet and The Lancet Neurology published the ICSS study and a substudy, respectively, online ahead of prin... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/evtoday/2010/02/article.asp?f=european-icss-study-concludes-cas-not-as-effective-as-cea-in-the-short-term http://bmctoday.net/evtoday/2010/02/article.asp?f=sleuth-shows-benefit-of-ekosrsquos-ultrasound-therapy-to-treat-brain-hemorrhage February 25, 2010—Ekos Corporation (Bothell, WA) announced that David W. Newell, MD, presented findings from the SLEUTH (Safety of Lysis With Ultrasound in the Treatment of Intracerebral [ICH] and Intraventricular Hemorrhage [IVH]) study at the International Stroke Conference in San Antonio, Texas. Dr. Newell is Co-Executive Director of the S... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/evtoday/2010/02/article.asp?f=sleuth-shows-benefit-of-ekosrsquos-ultrasound-therapy-to-treat-brain-hemorrhage http://bmctoday.net/evtoday/2010/02/article.asp?f=prognosis-of-patients-with-pad-shown-to-differ-by-disease-localization February 22, 2010—In the Journal of the American College of Cardiology, Victor Aboyans, MD, et al published finding from a single-center study that sought to assess the general prognosis of patients with peripheral arterial disease (PAD) according to the disease localization (2010;55:898–903). The background of the study is the understandin... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/evtoday/2010/02/article.asp?f=prognosis-of-patients-with-pad-shown-to-differ-by-disease-localization